Trefoil Therapeutics

Series-A
trefoiltherapeutics.com Biotech & Healthcare
Total Funding $28M
Latest Round $28M Series-A
Last Announced Dec 1, 2021
Investors Undisclosed
Decision Makers 3 Verified

About Trefoil Therapeutics

We are dedicated to restoring sight to the millions of people with corneal diseases through the advancement of therapies based on the inherent regenerative properties of naturally occurring corneal endothelial and epithelial cells.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website trefoiltherapeutics.com
Domain Registered Date Aug 30, 2013

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $28,000,000 · Series-A

    startupintros.com

  2. Milestone

    Website domain registered

    trefoiltherapeutics.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Trefoil Therapeutics.

Funding History

1 Round
Series-A · Dec 1, 2021

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts